Catalyst Wire Dossier Catalyst Wire Dossier

BI 653048 H3PO4 oral drinking solution

BI-653048 · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 653048 H3PO4 oral drinking solution, covering 2014-08-15 to 2014-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of BI 653048 H3PO4 Oral Drinking Solution in Healthy Male Volunteers [Phase 1]

See pricing